| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |